Table 2 Survival Estimates with Advanced Cancer
| Karnofsky | Median Survival |
| KS 50+ | 86 days |
| KS 30 - 40 | 50 days |
| KS 10 - 20 | 17 days |
| ECOG | Karnofsky | Median Survival |
| 0 | 100 asymptomatic | 34 weeks |
| 1 | 80-90 ambulatory | 24 - 27 weeks |
| 2 | 60-70 in bed <50% | 14-21 weeks |
| 3 | 40-50 in bed >50% | 7 - 9 weeks |
| 4 | 20-30 bedridden | 3 - 5 weeks |
| Mets | Survival | Perf. Score | Survival |
| 1 site | 31 months | PS 0 | 23 months |
| 2 sites | 24 months | PS 1 | 20 months |
| 3+ | 12 months | PS 2,3 | 14 months |
| Liver Involvement | Median Survival |
| < 20% | 24.5 months |
| 21 - 40% | 13.6 months |
| 41 - 60% | 8.8 months |
| > 60% | 6.1 months |
| Response to Radiation | Survival |
| complete response | 33 - 49 weeks |
| partial | 20 weeks |
| none | 9 - 14 weeks |
| Source | Solitary | Multiple |
| Breast | 73 weeks | 34 - 48 weeks |
| Prostate | 39 weeks | 25 - 30 weeks |
| Other | 33 weeks | 16 weeks |
| Lung | 14 weeks | 12 -22 weeks |